Skip to main content

PACS and RIS Market To Witness Substantial Growth Due To Growing Popularity of PACS around the World

 


Overview:

A PACS system is a database of medical images and other medical information. It is generally stored in an RIS, though radiologists may choose to view the results directly in PACS. Cloud PACS solutions, however, allow radiologists to access even more information. Moreover, many providers boast of being able to integrate PACS with RIS. However, they are unable to quantify the integration time. RIS and PACS solutions are designed to facilitate interoperability among imaging devices. This is done by creating a standardized communication interface based on DICOM standards. The RIS acts as a master system that provides image management and move control functions. 

Market Dynamics:

The popularity of PACS is growing all over the world and this is anticipated to propel growth of the global PACS and RIS market over the forecast period. PACS help to reduce the physical as well as time barriers linked to regular film-based retrieval, display and distribution of images. For instance, in August 2021, PaxeraHealth, developer of PACS/RIS announced to launch its novel product called PaxexaUltima 8th Generation, which is an AI-based imaging platform that provides AI algorithms for analyzing large data sets.

However, risk of cyber-attacks leading to growing concerns about safety of data in healthcare is likely to obstruct growth of the global PACS and RIS market over the forecast period.

Impact of COVID-19:

The coronavirus outbreak in China affected several industries around the world. Due to the virus outbreak many countries announced nationwide lockdowns. Several market activities including manufacturing, supply of raw materials and distribution activities were disrupted throughout this period. The demand for various products declined during the pandemic which adversely affected growth of several markets including the one in discussion. However, as many countries are lifting lockdown regulations, the market is likely to regain growth.

Key Takeaways:

·         The global PACS and RIS market is expected to grow with a CAGR of 6.8% over the forecast period due to growing number of health care facilities along with products of high value such as orthopedic PACS, cardiology PACS, and more. For instance, in July 2022, The Royal Orthopedic Hospital NHS Foundation Trust announced to deploy a novel cloud-based PACS to offer radiologist intelligent productivity tools.

·         North America is anticipated to witness substantial growth in the global PACS and RIS market over the forecast period. This is due to growing demand for health care and increasing government initiatives for R&D across the region.

·         Major players active in the global PACS and RIS market are Novarad, GENERAL ELECTRIC COMPANY, Cerner Corporation, Koninklijke Philips N.V., ScImage, Inc., FUJIFILM Holdings, PACSHealth, LLC, McKesson Corporation, IBM, Siemens Healthcare Private Limited, INFINITT North America Inc., Agfa-Gevaert Group, Avreo, and Allscripts Healthcare, LLC.

 

 

Comments

Popular posts from this blog

Disposable Infusion Extension Lines Market Is Growing Rapidly Due To Rise in Number of Chronic Disease Cases All Over the World

  Overview: The disposable infusion extension lines are an important part of insulin pump therapy. It allows continuous insulin delivery. It is also known as a butterfly vein set or a scalp vein set. The device consists of a hypodermic needle, flexible wings, and small bore tubing. The extension line is then attached to the insulin pump or other devices. The disposable infusion extension line market is dominated by North America. The rising incidence of road accidents is a major driving factor for the growth of the market in this region. Disposable Infusion Extension Lines Market Drivers:- Major driver for growth of the global disposable infusion extension lines market is increasing blood donation campaigns. According to a survey conducted by World Health Organization (WHO), in 2015, more than 51.2 million people in India donate blood annually. The survey also reports that the need for blood donation camps have increased due to rise in road accidents. According to a survey c...

Treprostinil Drugs Market - High Prevalence of Pulmonary Arterial Hypertension and R&D of New Formulations of Treprostinil to Augment Growth of market

  Treprostinil is an antihypertensive agent used to treat patients with pulmonary arterial hypertension. It can also be used in the treatment of Degos disease, an extremely rare disorder in which small and medium sized arteries become blocked (occlusive arteriopathy), restricting the flow of blood to affected areas. Market Dynamics High prevalence of pulmonary arterial hypertension is expected to propel growth of the treprostinil drugs market . For instance, according to the study, ‘High Geographic Prevalence of Pulmonary Artery Hypertension: Associations with Ethnicity, Drug Use, and Altitude’, published in February 2020, in the journal Pulmonary Circulation, the overall pulmonary arterial hypertension incidence was 14 cases per million and the annual period prevalence of pulmonary arterial hypertension was 93 cases per million. Decline in new prescriptions for treprostinil-based products is expected to hinder growth of the treprostinil drugs market. For instance, United The...